Human Oncology & Pathogenesis Program

The Kojo Elenitoba-Johnson and Megan Lim Lab

Research

Kojo S. Elenitoba-Johnson is the Chair of the Department of Pathology and Laboratory Medicine and a physician-scientist. Dr. Elenitoba-Johnson’s research focuses on the role of genomic and proteomic alterations in the pathogenesis of lymphomas.

Dr. Megan S. Lim is the Director of the Lymphoma Translational Research Program and Director of the Biofluid Biobank. Dr. Lim is a hematopathologist-scientist who studies the role of genomic and proteomic alterations in the pathogenesis of lymphoma.

The research interests of the Elenitoba-Johnson-Lim lab encompass genomic and functional proteomic approaches to discover novel mechanisms of lymphoma pathogenesis; development of conditional murine models for investigating the role of oncogenes and tumor suppressor genes in lymphocyte development and lymphomas genesis and translational research utilizing innovative genomic and mass spectrometry-based approaches focused on identification of novel genomic and proteomic targets for diagnostic and therapeutic applications.

Research Projects

Selected Projects

Lap PIs — Dr. Elenitoba- Johnson and Dr. Megan Lim

Featured News

Memorial Sloan Kettering Physician-Scientists Elected to the Prestigious National Academy of Medicine

Luis Diaz Jr., MD, Head of the Division of Solid Tumor Oncology, and incumbent of the Grayer Family Chair, and Kojo S.J. Elenitoba-Johnson, MD, Chair of the Department of Pathology and Laboratory Medicine, Member in the Human Oncology Pathogenesis Program (HOPP), and the incumbent of the James Ewing Alumni Chair of Pathology at Memorial Sloan Kettering Cancer Center (MSK), have been elected to the National Academy of Medicine (NAM), one of the highest honors bestowed upon scientists worldwide.

See Dr. Kojo Elenitoba-Johnson, the inaugural Chair of the MSK Department of Pathology and Laboratory Medicine.

Pinpoint Accuracy: How Dr. Elenitoba-Johnson Helps Lead the Diagnosis of Cancer at MSK

Learn about Dr. Kojo Elenitoba-Johnson, who leads teams of Memorial Sloan Kettering experts in interpreting lab tests and diagnosing cancer as the inaugural Chair of the MSK Department of Pathology and Laboratory Medicine. He is also a member in the Human Oncology and Pathogenesis Program.